BIDMC Genomics Center Director Libermann Discusses Vision of Genomic Techs in Trials | GenomeWeb

Name: Towia Libermann

Position: Associate Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 2000 — the present

Director of the Genomics Center, Beth Israel Deaconess Medical Center and Harvard Medical School, 1999 — the present

Director, Dana Farber/Harvard Cancer Center Cancer Proteomics Core, 2004 — the present

Background: Founder, Tolerance Pharmaceuticals, 1999

Education: MS, Biochemistry Federal Institute of Technology, Zurich, Switzerland, 1980

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.